Injection & split-dose log
Log each injection as you take it — split doses included — with site rotation so no spot gets overused. Every amount is yours; the app suggests nothing.
RetaLog is a personal tracking and education tool built for retatrutide only. Log each injection — split doses included — follow your estimated level curve on the ~6-day half-life model, track vials and run-out dates, and keep symptoms and resting heart rate alongside. No account. No ads. Everything stays on your device.
RetaLog is coming soon to Google Play. Until it lands, Vialera — our peptide tracker, live on Google Play now — already includes retatrutide tracking, and RetaLog restores Vialera backups, so nothing you log is lost when you switch.
Retatrutide is an investigational medicine. It is not approved by the FDA or any other regulator, and outside its clinical trials there is no legitimate retail sale for human use.
RetaLog is a personal tracking and education tool. It does not sell anything, does not link to any seller, and does not provide medical advice, diagnosis, treatment, or dose recommendations. Every amount in this app is entered by you. Talk to a qualified clinician about any protocol, and about whether any compound is legal or appropriate for you.
General peptide trackers spread themselves across a hundred compounds. RetaLog is designed around retatrutide alone — its ~6-day half-life, its weekly rhythm, its record-keeping.
Log each injection as you take it — split doses included — with site rotation so no spot gets overused. Every amount is yours; the app suggests nothing.
Your estimated level, modeled on retatrutide's ~6-day half-life and charted from the doses you actually logged — so the week ahead reads at a glance.
Vial and pen inventory with remaining amounts and run-out dates — you know when a vial runs out long before it does.
Your numbers, your math. Enter the vial and the water; RetaLog does the arithmetic. No suggested amounts, ever.
A symptom and resting heart-rate log kept beside your doses — your own records, in your own words. The app never interprets them or flags them.
TRIUMPH trial information and pharmacokinetics, presented as published trial information — never as a recommended schedule.
Real screens from RetaLog. Dark, quiet, and built to be checked in seconds — not scrolled for minutes.
Retatrutide's trial-reported effects — like skin sensitivity — are easier to spot in a written record than in memory. Log what you feel, when it started, and your resting heart rate beside it. RetaLog stores it and stays out of the interpretation business: if you feel unwell, it tells you to talk to a qualified healthcare professional.
What the trials actually reported, with the investigational warning at the top of the page — not buried under it. Published results are shown as research information, never as a promise of any individual's result, and never as a dosing guide.
RetaLog opens with the disclosure on the left, and you tap “I understand” before you log a single thing. That posture runs through everything we publish about this app:
No account. No ads. No analytics. No data sale. RetaLog doesn't even hold an internet permission — everything you log stays on your device, works fully offline, and uninstalling deletes it. This website collects nothing either: no cookies, no trackers.
Vialera is here now — and its retatrutide mode is the same tracking, live on Google Play today. Start there, and RetaLog will pick up your history when it launches.
Get Vialera on Google PlayRetaLog launches at $0.99 on Google Play, with an optional Pro subscription for level history and exports. Android first.